Drugs / Helium/Oxygen
last change May 2011 re-read 2 minutes ago

Helium/Oxygen

Developed for
chronic obstructive pulmonary disease
Investigated by
Air Liquide SA · Asklepios Kliniken Hamburg GmbH

Trials 1 · a red edge is where a trial was stopped

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01355809 Dec 2009 → Mar 2011 chronic obstructive pulmonary disease Air Liquide SA Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Helium/Oxygen ClinicalTrials.gov intervention name — accepted as the source's own label NCT01355809
Route Inhaled “Inhalated gas, Helium/Oxygen (65%/35%) one time by random, 6 minutes” NCT01355809